Clinical outcomes of active specific immunotherapy in advanced colorectal cancer and suspected minimal residual colorectal cancer: a meta-analysis and system review

BACKGROUND: To evaluate the objective clinical outcomes of active specific immunotherapy (ASI) in advanced colorectal cancer (advanced CRC) and suspected minimal residual colorectal cancer (suspected minimal residual CRC). METHODS: A search was conducted on Medline and Pub Med from January 1998 to J...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Benqiang, Han, Minyan, Wang, Lei, Gao, Xiaoyan, Huang, Jun, Huang, Meijin, Liu, Huanliang, Wang, Jianping
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041676/
https://www.ncbi.nlm.nih.gov/pubmed/21272332
http://dx.doi.org/10.1186/1479-5876-9-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041676/
https://www.ncbi.nlm.nih.gov/pubmed/21272332
http://dx.doi.org/10.1186/1479-5876-9-17

Ejemplares similares